Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 23, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Poor Response to Ovulation InductionInfertility, FemaleOvarian InsufficiencyOvarian FailureReproductive SterilityOvary; Anomaly
Interventions
BIOLOGICAL

Autologous platelet rich plasma

Preparation of PRP will be performed immediately following blood sample collection. Blood samples will be collected from the median antebrachial vein. PRP will be prepared according to the manufacturer's instructions employing a Regen Autologous Cellular Regeneration (ACR®-C) Kit (Regen Laboratory, Le Mont-sur-Lausanne, Switzerland). Approximately 60 mL of the patient's peripheral blood will be required in order to yield the required volume of PRP. The goal concentration of platelets in PRP is approximately 1.000.000 platelets/µL. The technique of PRP intraovarian infusion resembles the transvaginal paracentesis performed during the oocyte pick-up procedure. Briefly, both ovaries are visualized via transvaginal ultrasound monitoring, and they are intramedullary injected on multiple sites using a 17-gauge single lumen needle, with the patient under inhaled minimal sedation.

Trial Locations (1)

15232

RECRUITING

Genesis Athens Clinic, Athens

All Listed Sponsors
collaborator

National and Kapodistrian University of Athens

OTHER

lead

Genesis Athens Clinic

OTHER